C
RCUS icon

Covestor’s Arcus Biosciences RCUS Stock Holding History

Covestor’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1K Buy
25
+18
+257% +$445 ﹤0.01% 2301
2026
Q1 		$0 Hold
7
– – ﹤0.01% 2683
2025
Q4 		$0 Hold
7
– – ﹤0.01% 2653
2025
Q3 		$0 Sell
7
-180
-96% -$1.87K ﹤0.01% 2674
2025
Q2 		$2K Buy
187
+63
+51% +$538 ﹤0.01% 1882
2025
Q1 		$1K Sell
124
-21
-14% -$243 ﹤0.01% 2077
2024
Q4 		$2K Buy
145
+138
+1,971% +$2.25K ﹤0.01% 1931
2024
Q3 		$0 Hold
7
– – ﹤0.01% 2653
2024
Q2 		$0 Buy
7
+3
+75% +$48 ﹤0.01% 2654
2024
Q1 		$0 Sell
4
-1
-20% -$17 ﹤0.01% 2640
2023
Q4 		$0 Hold
5
– – ﹤0.01% 2604
2023
Q3 		$0 Sell
5
-1
-17% -$20 ﹤0.01% 2596
2023
Q2 		$0 Hold
6
– – ﹤0.01% 2545
2023
Q1 		$0 Hold
6
– – ﹤0.01% 2471
2022
Q4 		$0 Sell
6
-3
-33% -$83 ﹤0.01% 2498
2022
Q3 		$0 Sell
9
-1
-10% -$26 ﹤0.01% 2473
2022
Q2 		$0 Sell
10
-3
-23% -$73 ﹤0.01% 2279
2022
Q1 		$0 Sell
13
-4
-24% -$134 ﹤0.01% 2380
2021
Q4 		$1K Buy
+17
New +$659 ﹤0.01% 1899

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Covestor's RCUS Position: Q2 2026 in Review

Covestor increased its Arcus Biosciences (RCUS) stake by 257% in Q2 2026, buying an estimated $445 and bringing the position to 25 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2301.

Covestor first reported a position in RCUS in Q4 2021 and has held it in 19 quarters since. The position peaked at $2K in Q2 2025. 231 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Covestor held 25 shares of Arcus Biosciences worth $1K as of Q2 2026.
  • Covestor bought 18 Arcus Biosciences shares in Q2 2026, an estimated $445.
  • Arcus Biosciences made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2301 holding.
  • Covestor first reported a position in Arcus Biosciences in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Arcus Biosciences position peaked at $2K in Q2 2025.
  • 231 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.